Trichostatin A (TSA)

产品编号: DC8134 Featured
Trichostatin A (TSA)
结构式
58880-19-6
此产品仅供科研所需,我们不出售给病人
​我们将匹配市场上最好的价格给您
Email:order@dcbio.cn
免费咨询电话:4008862077
我们的合作伙伴:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
中国地区超过5000个高品质化合物库存
应用领域
Trichostatin A (TSA) 是有效的,特异的组蛋白去乙酰化酶类型 I 和 II (HDAC class I/II) 抑制剂,对 HDAC 的 IC50 值为 1.8 nM。
Cas No.: 58880-19-6
名称: (2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE
别名: Trichostatin A
SMILES: C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C
分子式: C17H22N2O3
分子量: 302.37
纯度:
保存条件: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description:
In Vivo:
In Vitro:
References: Trichostatin A inhibits the proliferation of eight breast carcinoma cell lines including MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51, and SK-BR-3 with mean IC50 of 124.4 nM (range, 26.4-308.1 nM), with more potency against cell lines that express ERα than the ERα-negative cell lines. Trichostatin A inhibits HDAC activity similarly in all the breast cancer cell lines with mean IC50 of 2.4 nM (range, 0.6-2.6 nM), and results in pronounced histone H4 hyperacetylation. Unlike Trapoxin (TPX) and Chlamydocin which potently inhibit HDAC1 or HDAC4 but not HDAC6, Trichostatin A inhibits these HDACs to a similar extent with IC50 of 6 nM, 38 nM, and 8.6 nM, respectively. Trichostatin A (100 ng/mL) treatment induces the expression of transforming growth factor β type II receptor (TβRII) in MIA PaCa-2 cells through the recruitment of p300 and PCAF into a Sp1-NF-Y HDAC complex that binds the DNA element of TβRII promoter, which is associated with a concomitant acetylation of Sp1 and an overall decrease in the amount of HDAC associated with the complex. Administration of Trichostatin A at 0.5 mg/kg for 4 weeks displays potent antitumor activity in the N-methyl-N-nitrosourea carcinogen-induced rat mammary carcinoma model, without any measurable toxicity at doses up to 5 mg/kg. Single intraperitoneal doses of 10 mg/kg Trichostatin A in nontransgenic and spinal muscular atrophy (SMA) model mice results in increased levels of acetylated H3 and H4 histones and modest increases in survival motor neuron (SMN) gene expression. Administration of Trichostatin A at 10 mg/kg/day improves survival, attenuates weight loss, and enhances motor behavior in the SMA model mice. For the detailed information of Trichostatin A (TSA), the solubility of Trichostatin A (TSA) in water, the solubility of Trichostatin A (TSA) in DMSO, the solubility of Trichostatin A (TSA) in PBS buffer, the animal experiment (test) of Trichostatin A (TSA), the cell expriment (test) of Trichostatin A (TSA), the in vivo, in vitro and clinical trial test of Trichostatin A (TSA), the EC50, IC50,and affinity,of Trichostatin A (TSA), For the detailed information of Trichostatin A (TSA), the solubility of Trichostatin A (TSA) in water, the solubility of Trichostatin A (TSA) in DMSO, the solubility of Trichostatin A (TSA) in PBS buffer, the animal experiment (test) of Trichostatin A (TSA), the cell expriment (test) of Trichostatin A (TSA), the in vivo, in vitro and clinical trial test of Trichostatin A (TSA), the EC50, IC50,and affinity,of Trichostatin A (TSA), Please contact DC Chemicals.
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
产品编号 产品名称 应用领域
DC3110 CUDC-907 (PI3K/HDAC InhibitorI) Fimepinostat (CUDC-907) 有效抑制 I 型 PI3K 及 I 和 II 型 HDAC 酶,作用于 PI3Kα/PI3Kβ/PI3Kδ 和 HDAC1/HDAC2/HDAC3/HDAC10 ,IC50 分别为 19/54/39 nM 和 1.7/5.0/1.8/2.8 nM。
DC9925 CXD101(AZD-9468) CXD101 是一种有效的,选择性的,具有口服活性的 I 类 HDAC 抑制剂,对 HDAC1,HDAC2 和 HDAC3 的 IC50 分别为 63 nM,570 nM 和 550 nM。CXD101 对 II 类 HDAC 没有活性,并具有抗肿瘤活性。
DC8828 HDAC inhibitor IV HDAC inhibitor IV is a cell-permeable pimeloylanilide compound that acts as a FXN- (frataxin gene) specific HDAC (histone deacetylase) inhibitor.
DC8663 UF010 UF010是一种有效的选择性HADC抑制剂, 作用于HDACs 3, 2, 1 和 8, IC50值分别为 0.06μM, 0.1μM, 0.5μM, 和1.5μM, 比作用于其他HDACs选择性高6倍多。
DC8661 Pimelic Diphenylamide 106 Pimelic Diphenylamide 106 是一种缓慢的, 结合紧密的I类HDAC抑制剂 (抑制HDAC1, 2和3, IC50值分别150 nM, 760nM, 和370 nM), 对II类HDAC没有活性。
DC8660 BML-210(CAY10433) BML-210 是一类新颖的HDAC抑制剂,其IC50值为5 μM。
DC8654 PTACH (NCH-51) PTACH (NCH-51) 是一种新型HDAC抑制剂, PTACH有效抑制各种人癌细胞生长, EC50值为1至10 μM。
DC8646 Remodelin Remodelin是乙酰基转移酶NAT10的新型强效选择性抑制剂。
DC8350 Droxinostat Droxinostat(NS41080)是HDAC3,HDAC6和HDAC8抑制剂,IC50分别为16.9,2.47和1.46 μM。
DC8310 BG-45 BG45是一个HDAC I型抑制剂, 选择性抑制HDAC3 (IC50=289 nM). BG45抑制HDAC1/2/ 6, 效力大大降低 (IC50分别为2, 2.2, 和 >20μM)。